Cyclin D3 Recombinant Antibody

$25 ug total protein per lane of various lysates (see on figure) probed with Cyclin D3 monoclonal antibody, unconjugated (bsm-52047R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.$

25 ug total protein per lane of various lysates (see on figure) probed with Cyclin D3 monoclonal antibody, unconjugated (bsm-52047R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.

Applications

WB
IF(ICC)

Reactivity

Human
Rat

Overview
Catalog #	bsm-52047r
Product Name	Cyclin D3 Recombinant Antibody
Applications	WB IF(ICC)
Reactivity	Human, Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	Recombinant human Cyclin D3 protein, around C-terminal 200aa
Clonality	Recombinant
Clone #	4A8
Isotype	IgG
Concentration	Lot Dependent
Purification	purified by Protein A.
Storage Buffer	0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	896
Swiss Prot	P30281
Subcellular location	Cytoplasm, Nucleus, Cell membrane
Synonyms	9230106B05Rik; CCND3_BOVIN; CCND3; CCND3_HUMAN; CCND3_MOUSE; Cyl-3; CCND3_RAT; cyclin D3
Background	Regulatory component of the cyclin D3-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity. Component of the ternary complex, cyclin D3/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex.
Application Dilution
WB	1:300-5000
IF(ICC)	1:50-200